General Information


DRAVP ID  DRAVPe00818

Peptide Name   IZN36

Sequence  IKKEIEAIKKEQEAIKKKIEAIEKEISGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL

Sequence Length  62

UniProt ID  No entry found

Source  Synthetic construct

Other Link  DRAVPa0197



Activity Information


Target Organism  HIV

Assay  HIV luciferase assay

Activity 

  • [Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and HOS-CD4/fusion cells(IC50=0.026±0.007 µM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  membrane

Mechanism  The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00818

Linear/Cyclic  Linear

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C323H555N91O92

Absent amino acids  CDFMPY

Common amino acids  I

Mass  7185.51

Pl  9.46

Basic residues  12

Acidic residues  8

Hydrophobic residues  27

Net charge  4

Boman Index  -9633

Hydrophobicity  -35

Aliphatic Index  132.26

Half Life 

  •     Mammalian:20 hour
  •     Yeast:30 min
  •     E.coli:>10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  90.16

Polar residues  6



Literature Information


Literature 1

Title   Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.

Pubmed ID   11572974

Reference   Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.

Author   Eckert DM, Kim PS.

DOI   10.1073/pnas.201392898